EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Long-term efficacy of garadacimab in patients with hereditary angioedema from the Phase 3 open-label extension study: an up to 3-year interim analysis

Saturday 14 Jun, 15:12 PM - 15:24 PM Glasgow, United Kingdom